Formulations of pimavanserin | Patent Publication Number 20200009122

US 20200009122 A1

Patent NumberUS 10646480 B2

Application Number16571554

Filled DateSep 16, 2019

Priority Date-

Publication DateJan 9, 2020

Original AssigneeAcadia Pharmaceuticals Inc.

Current AssigneeAcadia Pharmaceuticals Inc.

Inventor/ApplicantsRavi Tejwani
Stephen Edward Abele
Emanuel Joseph Vizzotti

Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.

Check our Latest Report Purchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.